Find clinical trials for Acute Myeloid Leukemia (AML) in Sevilla, AN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Sevilla, AN, ESP:
The main objective of this study is to evaluate the efficacy of venetoclax in combination with azacitidine to improve Overall Survival (OS) in Acute...
Phase 3
Sevilla, Spain and 164 other locations
will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...
Phase 1, Phase 2
Sevilla, Spain and 55 other locations
when administered to adult patients with relapsed or refractory acute myeloid leukemia (AML) or relapsed or progr...
Phase 2
Sevilla, Spain and 40 other locations
of standard chemotherapy plus quizartinib versus standard chemotherapy plus placebo in adult patients with newly diagnosed FLT3 wild-type Acute...
Phase 2
Sevilla, Spain and 44 other locations
A Phase 1 first-in-human dose-escalation and dose-expansion study of BMF-219, an oral covalent menin inhibitor, in adult patients with AML, ...
Phase 1
Sevilla, Spain and 40 other locations
of JNJ-90189892 in participants with relapsed or refractory (R/R) acute myeloid leukemia (AML) or R/R higher-risk...
Phase 1
Sevilla, Spain and 5 other locations
combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...
Phase 3
Seville, Spain and 264 other locations
administered in combination with venetoclax to adult patients with acute myeloid leukemia (AML) who are relapsed ...
Phase 2
Sevilla, Spain and 36 other locations
monotherapy and in combination with azacitidine in participants with acute myeloid leukemia (AML) and myelodyspla...
Phase 1, Phase 2
Sevilla, Spain and 49 other locations
available therapy (BAT) on overall survival (OS) in subjects with acute myeloid leukemia (AML) who are in second ...
Phase 3
Sevilla, Spain and 72 other locations
Clinical trials
Research sites
Resources
Legal